Recipharm AB has acquired Cobra Biomanufacturing and combined it with its existing biologics business in Sweden. The integrated companies will be called RecipharmCobra Biologics and will operate as Recipharm’s specialist biologics division. The acquisition creates a biological service offering that includes cell line development, analytical and process development and GMP production of recombinant proteins, DNA, viruses and cell products for Phase I – III trials, as well as fill-finish ...